Pharmaron at ELRIG’s Drug Discovery 2024
On October 2nd and 3rd, the Pharmaron team was delighted to attend ELRIG’s Drug Discovery 2024 as Silver Sponsors.
As part of Pharmaron’s sponsorship, Dr John Maclean (Senior Principal Scientist of Computational Chemistry) gave a 30-minute presentation entitled “Discovery of Novel Series of Selective Macrocyclic PKCθ Inhibitors.” The talk, attended by approximately 133 people, focused on the scientific advancements commencing within the Pharmaron team and the thriving collaboration with Galderma.
These posters highlighted groundbreaking research projects, from synthetic methodologies and data integration to protein degrader discovery.
Beyond the presentations and posters, the event was a fantastic opportunity for the Pharmaron team to connect with industry leaders and collaborators. ELRIG Drug Discovery 2024 was a highly successful event for the Pharmaron team. We are grateful to everyone who stopped by our Booth, attended our presentations, or connected with us during the conference.
Stay tuned for more updates via the Pharmaron Knowledge Centre, or contact our team to learn how we can support your drug discovery efforts. The ELRIG posters are linked below.
